Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
8 studies found for:    DIPAK
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Lanreotide to Treat Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Drug: Lanreotide
2 Recruiting Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)
Condition: Permanent Atrial Fibrillation
Interventions: Drug: Bisoprolol;   Drug: Digoxin
3 Not yet recruiting Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study
Condition: Primary Percutaneous Coronary Intervention
Intervention: Drug: Enoxaparin
4 Active, not recruiting Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma
Conditions: Lung Cancer;   Lymphoma;   Non-small Cell Lung Cancer;   Non-Hodgkin Lymphoma;   Mediastinal Lymphadenopathy
Intervention: Other: Cohort
5 Recruiting Cardiovascular Longitudinal Evaluation & Assessment of Risk (CLEAR) Study
Condition: Cardiovascular Disease
6 Terminated A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
Condition: Seasonal Allergic Conjunctivitis to Ragweed
Intervention: Drug: Olopatadine
7 Active, not recruiting Alternative Risk Markers in Coronary Artery Disease (ARMCAD)
Condition: Coronary Artery Disease
8 Unknown  Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure
Condition: Heart Failure
Interventions: Drug: Beta blocker;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.